Aubrey Organics Age Defying Therapy Natural Anti Ageing Skin Care Sea Buckthorn – Video

Posted on by


Aubrey Organics Age Defying Therapy Natural Anti Ageing Skin Care Sea Buckthorn
http://www.theremustbeabetterway.co.uk/brand/aubrey-organics.html?cat=553 Aubrey Organics Age Defying Therapy Natural Anti Ageing Skin Care Beauty Aubrey #39;s newly reformulated product lines...

By: Eczema

Go here to see the original:

Aubrey Organics Age Defying Therapy Natural Anti Ageing Skin Care Sea Buckthorn - Video

Graying America, Health-Care Overhaul Boosts Medical Properties

Posted on by

By Peter Grant And Robbie Whelan

Investors are pouring money into buying and developing senior housing, medical-office buildings and other health- care-related properties, a class of commercial real estate that has been outperforming almost all others since the recession.

The country's aging population and recovering economy, as well as major changes taking place in the economics of health care, are fueling demand for more space.

Investors are gravitating to health-care real estate in part because it held up well during the downturn. Since 2007, health-care real-estate investment trusts have outperformed all other property types except for manufactured homes and self-storage facilities, according to the National Association of Real Estate Investment Trusts.

Investors also are betting the Affordable Care Act will translate into millions more visits to doctors by patients who are getting insurance for the first time. Last year, health-care-focused REIT shares produced total returns of 35.5% , including dividends, Nareit said.

The strong performance and new money flowing into the sector are signs that many investors want to stick with properties that are more recession-resistant. The memory of the pain suffered by owners of office buildings, stores, hotels and many other types of property still runs deep.

Health-care property "has a stability factor that's very attractive," says John Sweet, chief investment officer of Physicians Realty Trust, a real-estate investment trust that went public in 2013 at $11.50 a share. It traded recently at about $17.25.

Sales and construction activity have been surging. In all, about $5 billion in medical-office buildings were sold last year in the U.S., a record, up from $4.3 billion in 2013, according to John Smelter of the real-estate firm Marcus & Millichap. About 8 million square feet of new medical-office buildings were delivered, up from 7 million in 2013, but far short of the more than 26.5 million square feet delivered in 2008, Mr. Smelter said.

Medical-related housing--ranging from apartment complexes that exclude younger people to nursing facilities with 24-hour-a-day care--also is experiencing a boom. Sales transactions involving senior housing and nursing facilities rose to $17.4 billion in 2014 from $14.8 billion in 2013, according to the National Investment Center for Seniors Housing & Care, a Maryland nonprofit organization that tracks investment in the senior-housing real-estate sector.

Construction of assisted-living facilities, which provide more care than regular apartments but less care than nursing homes, is running at more than twice the amount of 2008 to 2011. There were 11,268 units under construction at the end of 2014, compared with the long-term average of 5,450 units under construction each quarter between the end of 2008 and the end of 2011.

Read more:

Graying America, Health-Care Overhaul Boosts Medical Properties

Taking genetic mapping to the next level

Posted on by

Already, this genetic mapping and analysis, a key component of the emerging medical specialty known as precision medicine, is being practiced at various academic centers and private specialist doctors' offices. With a trained practitioner and the appropriate diagnostics, you can learn if you have a genetic predisposition to early menopause, for instance, allowing you the chance to decide whether to get pregnant now, or to freeze your eggs. Or if you're in danger of a heart attack, even though you are a triathlete. Or if you have a predisposition to a disease, that in your case can be sparked by stress, giving you the time to explore meditation, if not medication.

Read More Obama defiantly pushes agenda in State of the Union

This proactive and deeply personalized approach is clearly the future of medicine. But with President Obama's announcement of a new precision medicine Initiative during his State of the Union address, we may see an acceleration of both the funding and availability for this wealth of genetic data.

The president gave little detail.

He said: "Tonight, I'm launching a new Precision Medicine Initiative to bring us closer to curing diseases like cancer and diabetes and to give all of us access to the personalized information we need to keep ourselves and our families healthier."

Read MoreDrug deal to target cancer at genetic level: CEO

The White House has promised more information about what all of this means. But a few things are apparent:

First, the attention and funding that could come to this field will be of tremendous benefit to vitality and life spans. Twenty-first century technology and its interpretation by adept clinicians will allow individuals to drill down beneath their surfaces, deep into the complex cellular substance of life and the genetic material that makes each of us a uniquely functioning laboratory.

Second, expanded precision medicine availability will be a colossal disruptor of many health-care system components, from family doctors to hospital systems to medical insurers. Once this approach takes hold in the popular perception, the health-care consumer particularly the baby boomers will seek greater ownership of their personal health destiny.

Lastly, complex raw data require expert analysis, and there will be a wide and frustrating gap, especially at first, between the promise of what can be done with genetic information and the realities of understanding the data and making it actionable. Already, this has occurred with 23andMe, the mail-in genetic reporting kit that had to stop selling part of its service due to FDA objections. The raw data need expert translation to be meaningful.

Follow this link:

Taking genetic mapping to the next level

Recombinant Coagulation Factors 2015: Maturation Of Recombinant Clotting Factor Pipeline And Emergence Of Gene Therapy …

Posted on by

DUBLIN, January 27, 2015 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/pfd99m/recombinant) has announced the addition of the "Recombinant Coagulation Factors 2015: Maturation Of Recombinant Clotting Factor Pipeline And Emergence Of Gene Therapy And Alternative Procoagulants" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )

A Pipeline Landscape Analysis and Comparative Assessment of Key Players

This report provides an update of recombinant coagulation factors used for controlling bleeding of hemophilia A and B and other bleeding disorders. 2013 sales figures and 2014 nine-month sales data are analyzed to evaluate commercial development of the market under the light of a strong pipeline and entry of new competitor products into the market. The profiles of drug candidates in development are presented in details not only for recombinant coagulation factors VIII, IX and VII, but also for emerging alternative procoagulants, gene therapeutics and immune tolerance inducing agents.

The competitve landscape of classical recombinant coagulation factors and of new emerging treatment modalities of hemophilia and other severe bleeding orders is analyzed. The emergence of new treatment modalities brings many new stakeholders to the field of hemophilia. Among them are the established hemophilia portofolio companies, but also new entrants from Big Pharma and Big Biotech, specialty pharmaceutical companies, biosimilar companies, and new technology providers as half-life prolongation technologies are no longer in the focus of major interest.

A short- to mid-term outlook into the field is provided and the trends driving the future of this therapeutic segment are identified and described. Preparation of this report is based on information stored in La Merie Publishing's proprietary data base and news archive, on scientific literature, and on corporate disclosures. The data are presented, analyzed and assessed in a comprehensive manner by an experienced author with an independent view writing the fifth edition of this report series.

Key Topics Covered:

1. Executive Summary

2. Recombinant Coagulation Factor Markets 2.1 Recombinant Factor VIII (rFVIII) Product Sales and Market Size 2.2 Recombinant Factor IX (rFIX) Product Sales and Market Size 2.3 Recombinant Factor VII (rFVII) Product Sales and Market Size 2.4 Recombinant Thrombin Product Sales and Market Size 2.5 Total Recombinant Coagulation Factor Market Size

3. Pipeline Update of Recombinant Coagulation Factors 3.1 Factor VIII Pipeline Changes and Drug Profile Updates 3.2 Factor IX Pipeline Changes and Drug Profile Updates 3.3 Factor VII Pipeline Changes and Drug Profile Updates 3.4 Pipeline Update for Other Recombinant Coagulation Factors 3.5 Pipeline Update for Alternative Procoagulants 3.6 Pipeline Update for Gene & Cell Therapy 3.7 Immune Tolerance Inducing (ITI) Agents

View original post here:

Recombinant Coagulation Factors 2015: Maturation Of Recombinant Clotting Factor Pipeline And Emergence Of Gene Therapy ...

Future Business Trends in Biking to be Addressed by Futurist Jack Uldrich

Posted on by

Phoenix, AZ (PRWEB) January 28, 2015

Charles M. Schulz, author of the Peanuts cartoon, once famously said, "Life is like a ten speed bicycle. Most of us have gears we never use." "Nothing could be more true in today's world where our metaphorical gears are increasing at warp speed," says futurist Jack Uldrich. Uldrich will be addressing the Independent Bike Dealers (IBD) Summit, in Tempe, Arizona on Thursday, January 29th with his keynote address, "Business as Unusual" which will focus on how the IBD can start future-proofing their businesses against the trends of tomorrow.

Highly acclaimed speaker and best selling author Jack Uldrich travels the world addressing a wide variety of organizations from telecommunications to healthcare, manufacturing to education. His message is clear: The future is predictably unpredictable. And the way to prepare for it is by embracing the paradox of seeing your own ignorance as the path to wisdom.

From the League of Innovation to Pfizer and Verizon, Uldrich addresses the top business trends affecting all of these industries. In one of his latest blog posts he covers the top ten technological trends that will transform the world in 2015. When it comes to the IBD, Uldrich says the trends in nanotechnology, manufacturing and 3D printing will in all likelihood have the most impact.

While the need for speed may be the goal some consumers have in mind when it comes to cycling, others are looking at the quality of the bikes themselves with the materials that are light and long lasting. Others simply want to know that the simple joys of biking won't be undone by the technological advances. In other words, that the gears beyond 10 won't complicate life so much that getting out on the trail or road will inhibit the joys of a good ride.

In addressing organizations like The Entrepreneurs Organization and IBD, Uldrich aims to inform these innovative business people of the trends that are coming their way and to encourage them to embrace his acronym of AHA---Awareness, Humility and Action---as fundamental tools that will guide them through the technological tides of change. "While technology may be changing at warp speed, good business sense is firmly rooted in these principles of the past. The paradox of embracing both is crucial to an independent dealer's success."

Parties interested in learning more about Jack, his books, his daily blog or his speaking availability are encouraged to visit his website. Media wishing to know more about this specific event or those interested in scheduling an interview with Jack can contact Amy Tomczyk at (651) 343.0660.

More:

Future Business Trends in Biking to be Addressed by Futurist Jack Uldrich

T. J. Demos – ‘Gardens Beyond Eden Bio aesthetics Eco futurism and Dystopia at dOCUMENTA (13)’ – Video

Posted on by


T. J. Demos - #39;Gardens Beyond Eden Bio aesthetics Eco futurism and Dystopia at dOCUMENTA (13) #39;
Tuesday Talks at The White Building: T.J. Demos, Gardens Beyond Eden:Bio-aesthetics, Eco-futurism and Dystopia at dOCUMENTA (13) Gardens Beyond Eden 18 June 2013, The White Building ...

By: Video in Common

Continue reading here:

T. J. Demos - 'Gardens Beyond Eden Bio aesthetics Eco futurism and Dystopia at dOCUMENTA (13)' - Video

Ming City Rockers – Full Set (Hull Freedom Festival – 6th September 2014) – Video

Posted on by


Ming City Rockers - Full Set (Hull Freedom Festival - 6th September 2014)
Ming City Rockers performing at Hull Freedom Festival on 6th September 2014. Recorded with a Sony DSC-HX50. Set List: 1. Chic the Motherfuckers 2. Runaway (Cover) 3. I Wanna Get Out Of...

By: Karlosvandingo

Read more:

Ming City Rockers - Full Set (Hull Freedom Festival - 6th September 2014) - Video

Assassin’s Creed 4: Freedom Cry Gameplay Walkthrough Part 6: Sherlock Holmes – Video

Posted on by


Assassin #39;s Creed 4: Freedom Cry Gameplay Walkthrough Part 6: Sherlock Holmes
Playlist: https://www.youtube.com/playlist?list=PLq1vVW_6dMFUirMDNLnx2wla_aZAssdXN such investigation much teed How to contact me Twitter- https://twitter.com/chimmychunger Facebook-.

By: chimmychunger

See the original post here:

Assassin's Creed 4: Freedom Cry Gameplay Walkthrough Part 6: Sherlock Holmes - Video